United Kingdom recommendations for obstetric venous thromboembolism prophylaxis: Evidence and rationale

Semin Perinatol. 2019 Jun;43(4):222-228. doi: 10.1053/j.semperi.2019.03.008. Epub 2019 Mar 9.

Abstract

Venous thromboembolism (VTE) is a leading cause of maternal death in the United Kingdom. To address this problem guidance from the Royal College of Obstetricians and Gynaecologists (RCOG) has been developed that recommends the assessment of a woman's risk of thrombosis at specific time-points during pregnancy and postnatally at the time of delivery. The RCOG guidelines provide clinicians with a framework to inform decision-making on the use of thromboprophylaxis and are based on the premise that the higher risk a woman has for VTE, the more likely she is to benefit from prophylaxis - determining her level of risk is based on the number and characteristics of the risk factors that she has. This article will address the pathophysiology of VTE in pregnancy, evidence behind the risk factors for VTE and the use of thromboprophylactic agents. Further, it will reflect on the rationale behind the RCOG guidance.

Keywords: Guidelines; Pregnancy; Royal College of Obstetricians and Gynaecologists; Thromboprophylaxis; Venous thromboembolism.

Publication types

  • Review

MeSH terms

  • Adult
  • Anticoagulants / adverse effects
  • Anticoagulants / therapeutic use
  • Body Mass Index
  • Female
  • Humans
  • Postpartum Period
  • Practice Guidelines as Topic
  • Pregnancy
  • Pregnancy Complications, Cardiovascular / prevention & control*
  • Risk Assessment
  • Risk Factors
  • United Kingdom
  • Venous Thromboembolism / complications*
  • Venous Thromboembolism / prevention & control*

Substances

  • Anticoagulants